Radiotherapy and Oncology, 0167-8140


Related Publications
  1. Reprint of: Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement

    Thomson, D. J., Palma, D., Guckenberger, M., Balermpas, P., Beitler, J. J., Blanchard, P., Brizel, D., Budach, W., Caudell, J., Corry, J., Corvo, R., Evans, M., Garden, A. S., Giralt, J., Gregoire, V., Harari, P. M., Harrington, K., Hitchcock, Y. J., Johansen, J., Kaanders, J., Koyfman, S., Langendijk, J. A., Le, Q-T., Lee, N., Margalit, D., Mierzwa, M., Porceddu, S., Soong, Y. L., Sun, Y., Thariat, J., Waldron, J. & Yom, S. S., 27-Jul-2020, In : Radiotherapy and Oncology.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy

    van der Heijden, M., Essers, P. B. M., Verhagen, C. V. M., Willems, S. M., Sanders, J., de Roest, R. H., Vossen, D. M., Leemans, C. R., Verheij, M., Brakenhoff, R. H., van den Brekel, M. W. M. & Vens, C., 2020, In : Radiotherapy and Oncology. 23 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Can we safely reduce the radiation dose to the heart while compromising the dose to the lungs in oesophageal cancer patients?

    Beukema, J. C., Kawaguchi, Y., Sijtsema, N. M., Zhai, T-T., Langendijk, J. A., van Dijk, L. V., van Luijk, P., Teshima, T. & Muijs, C. T., Aug-2020, In : Radiotherapy and Oncology. 149, 6 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (281) »

ID: 684357